ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Pain Medicine

Top Pain Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ARASH YADEGAR M.D.

Pain Medicine

383

$26.4K

145
102 are 65+

29%
patients receiving schedule two controlled substances

Avg: 30%

23%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $100

LUKE RIGOLOSI MD

Pain Medicine

499

$38.8K

140
103 are 65+

19%
patients receiving schedule two controlled substances

Avg: 30%

39%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $100

DANIEL PERRI MD

Pain Medicine

1,277

$118K

140
86 are 65+

43%
patients receiving schedule two controlled substances

Avg: 30%

28%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$92
Average prescription price

Avg: $100

SYED RAHMAN M.D.

Pain Medicine

640

$35.8K

139
102 are 65+

12%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $100

MARIA CABODEVILLA-CONN MD

Pain Medicine

728

$65.5K

139
54 are 65+

65%
patients receiving schedule two controlled substances

Avg: 30%

31%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $100

CY BLANCO M.D.

Pain Medicine

522

$62.1K

138
82 are 65+

47%
patients receiving schedule two controlled substances

Avg: 30%

24%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$119
Average prescription price

Avg: $100

JOSEPH BAX D.O.

Pain Medicine

546

$34.1K

131
78 are 65+

57%
patients receiving schedule two controlled substances

Avg: 30%

24%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

SAMANT VIRK MD

Pain Medicine

564

$46.7K

130
71 are 65+

30%
patients receiving schedule two controlled substances

Avg: 30%

8%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $100

MUHAMMAD KHAN MD

Pain Medicine

2,347

$139K

129
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $100

MATTHEW KALTER M.D.

Pain Medicine

808

$90.3K

128
72 are 65+

40%
patients receiving schedule two controlled substances

Avg: 30%

22%
patients receiving schedule three controlled substances

Avg: 18%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $100

DAVID SPEACH M.D.

Pain Medicine

398

$14K

126
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

21%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 24%

$35
Average prescription price

Avg: $100

SYED HUSAIN D.O.

Pain Medicine

547

$50.7K

126
74 are 65+

29%
patients receiving schedule two controlled substances

Avg: 30%

12%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $100

JEFFREY PERRY DO

Pain Medicine

270

$15.4K

124
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $100

DANIEL KOHANE M.D.

Pain Medicine

638

$47.8K

123
71 are 65+

59%
patients receiving schedule two controlled substances

Avg: 30%

25%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $100

SEEMA NAMBIAR MD

Pain Medicine

955

$112K

115
69 are 65+

33%
patients receiving schedule two controlled substances

Avg: 30%

16%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$118
Average prescription price

Avg: $100

STEVEN WEINSTEIN M.D.

Pain Medicine

506

$31.2K

110
69 are 65+

25%
patients receiving schedule two controlled substances

Avg: 30%

35%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

ENRIQUE SANZ M.D.

Pain Medicine

297

$11.3K

108
60 are 65+

16%
patients receiving schedule two controlled substances

Avg: 30%

30%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $100

QUENTIN PHUNG MD

Pain Medicine

598

$24.4K

107
48 are 65+

21%
patients receiving schedule two controlled substances

Avg: 30%

37%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $100

XIAO FANG M.D.

Pain Medicine

1,065

$109K

103
25 are 65+

41%
patients receiving schedule two controlled substances

Avg: 30%

30%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$102
Average prescription price

Avg: $100

JOHN VLATTAS MD

Pain Medicine

641

$40K

103
46 are 65+

35%
patients receiving schedule two controlled substances

Avg: 30%

50%
patients receiving schedule three controlled substances

Avg: 18%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

RICHARD GASALBERTI MD

Pain Medicine

208

$32.6K

91
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

59%
prescriptions for brand name drugs

Avg: 24%

$157
Average prescription price

Avg: $100

VIJAY SIDHWANI D.O.

Pain Medicine

945

$197K

91
47 are 65+

53%
patients receiving schedule two controlled substances

Avg: 30%

15%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$208
Average prescription price

Avg: $100

LARISA TSAUR MD

Pain Medicine

942

$111K

91
60 are 65+

19%
patients receiving schedule two controlled substances

Avg: 30%

18%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 24%

$118
Average prescription price

Avg: $100

REUBEN INGBER

Pain Medicine

513

$93.5K

85
63 are 65+

41%
patients receiving schedule two controlled substances

Avg: 30%

18%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$182
Average prescription price

Avg: $100

JOSEPH HERRERA D.O.

Pain Medicine

479

$64.7K

85
58 are 65+

28%
patients receiving schedule two controlled substances

Avg: 30%

18%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$135
Average prescription price

Avg: $100

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank